跳至主要内容
临床试验/CTRI/2018/07/014984
CTRI/2018/07/014984招募中未知

Comparison of the efficacy of 2.5 mg versus 5 mg Ulipristal Acetate in the treatment of symptomatic uterine fibroids.

Jagsonpal Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. At least 1 fibroid >3.0 CM in one dimension,
  • 2. Symptomatic fibroid (PBAC >100)
  • 3. Grade 2-7 fibroids (FIGO Classification)

排除标准

  • 1. Post-menopausal women.
  • 2. Asymptomatic women with uterine fibroids
  • 3. Fibroid size <3.0 cm (smallest dimension)
  • 4. Grade 0-1 fibroids
  • 5. Uterine size >20 weeks
  • 6. Undergoing or having received medical/hormonal treatment for fibroids in the last 3 months
  • 7. Clinical suspicion/USG features suggestive of adenomyosis.
  • 8. History of uterine artery embolization.
  • 9. Suspected or known case of gynecological cancer/atypical endometrial hyperplasia.

研究者

发起方
Jagsonpal Pharmaceuticals Ltd

相似试验